INSM1: Insulinoma-Associated Protein 1

Transcriptional regulator in neuroendocrine differentiation and tumorigenesis

Gene Information Card

Symbol INSM1
Full Name Insulinoma-Associated Protein 1
Gene Type Protein coding
Chromosomal Location 20p11.23
NCBI Gene ID 3642 ncbi.nlm.nih.gov/gene/3642
Ensembl ID ENSG00000101204
UniProt ID Q01101
OMIM ID 600010
HGNC ID 6090
Aliases IA-1, IA1

Description

INSM1 (Insulinoma-Associated Protein 1) encodes a zinc-finger transcription factor that plays a critical role in neuroendocrine differentiation and development. It is expressed in developing neuroendocrine tissues and is frequently re-expressed in neuroendocrine tumors, serving as a diagnostic and prognostic biomarker. INSM1 regulates genes involved in cell cycle, apoptosis, and neuroendocrine lineage specification.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Neuroendocrine tumors (e.g., insulinoma, small cell lung carcinoma, medullary thyroid carcinoma) Overexpression of INSM1 promotes neuroendocrine differentiation and tumor growth by activating downstream targets such as ASCL1 and inhibiting apoptosis ClinVar, COSMIC, NCBI Gene
Pheochromocytoma INSM1 is highly expressed in chromaffin cell-derived tumors, contributing to catecholamine synthesis and tumor progression NCBI Gene, OMIM
Merkel cell carcinoma INSM1 expression is a sensitive marker for Merkel cell carcinoma, aiding in differential diagnosis ClinVar, COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Pancreas 12.5 Medium
Adrenal gland 8.3 Low
Thyroid 6.1 Low
Lung 2.4 Not detected
Brain 1.8 Not detected
Cell Line Expression
Cell Line nTPM Notes
NCI-H69 (small cell lung cancer) 45.2 High expression; neuroendocrine lineage
BON-1 (pancreatic carcinoid) 38.7 High expression; insulinoma model
TT (medullary thyroid carcinoma) 29.1 High expression; neuroendocrine tumor
HEK293 (embryonic kidney) 0.5 Low/not detected; non-neuroendocrine
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense Rare Loss of start codon; likely loss of function
c.100C>T (p.Arg34Trp) Missense Rare Altered DNA-binding domain; reduced transcriptional activity
c.250G>A (p.Gly84Ser) Missense Rare Unknown functional effect; reported in neuroendocrine tumors
Mutation functional classification

Loss of Function (LOF)

Mutations affecting the zinc-finger domain or start codon reduce DNA binding and transcriptional activation, impairing neuroendocrine differentiation.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported; overexpression in tumors is primarily due to transcriptional upregulation rather than activating mutations.

Dominant Negative (DN)

No dominant-negative mutations described in the literature.

Pathways

Neuroendocrine differentiation pathway (ASCL1-INSM1 axis)
Notch signaling pathway (INSM1 represses Notch targets)
Cell cycle regulation (p21/CDKN1A modulation)

Protein Summary

INSM1 is a 510-amino acid zinc-finger transcription factor localized to the nucleus. It contains five C2H2-type zinc fingers that mediate sequence-specific DNA binding. INSM1 acts as both a transcriptional repressor and activator, regulating genes involved in neuroendocrine differentiation, cell cycle arrest, and apoptosis. It is a key marker for neuroendocrine tumors and is used in immunohistochemistry for diagnostic purposes.

Related Products

Product name Cat.No. Species Gene ID
INSM1 Knockout HEK293 Cell Line EDJ-KQ1916 Human 3642 Details Get a Quote
INSM1 Knockout HeLa Cell Line EDJ-KQ53668 Human 3642 Details Get a Quote
INSM1 Knockout A-549 Cell Line EDJ-KQ62142 Human 3642 Details Get a Quote
INSM1 Knockout HCT 116 Cell Line EDJ-KQ70633 Human 3642 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: